Table 4.
Adverse events associated with cardiopulmonary functions in each group.
| Total | Group A (n = 149) | Group B (n = 33) | P value | |
|---|---|---|---|---|
| Hypoxia (%) | 31/182 (17.0) | 28/149 (18.8) | 3/33 (9.1) | 0.1798 |
| Hypotension (%) | 26/182 (14.3) | 17/149 (11.4) | 9/33 (27.3%) | 0.0185 |
| Bradycardia (%) | 2/182 (1.1) | 2 /149 (1.3) | 0/149 (0) | 0.7999 |
|
| ||||
| Total (%) | 59/182 (32.4) | 47/149 (31.5) | 12/33 (36.4) | 0.7416 |
Group A: control group consisting of patients with mild acute cholangitis or without acute cholangitis.
Group B: more severe general condition group consisting of patients with severe or moderate acute cholangitis.